Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
Jongen PJ, Ruimschotel R, Heerings M, Hussaarts A, Duyverman L, van der Zande A, Valkenburg-Vissers J, Wolper H, van Droffelaar M, Lemmens W, Donders R, Visser LH. Jongen PJ, et al. Among authors: visser lh. Health Qual Life Outcomes. 2014 Mar 19;12:40. doi: 10.1186/1477-7525-12-40. Health Qual Life Outcomes. 2014. PMID: 24646061 Free PMC article.
Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis.
Jongen PJ, Wesnes K, van Geel B, Pop P, Sanders E, Schrijver H, Visser LH, Gilhuis HJ, Sinnige LG, Brands AM; COGNISEC Study Group. Jongen PJ, et al. Among authors: visser lh. PLoS One. 2014 May 1;9(5):e96444. doi: 10.1371/journal.pone.0096444. eCollection 2014. PLoS One. 2014. PMID: 24787714 Free PMC article.
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study.
Jongen PJ, Lehnick D, Koeman J, Frequin S, Heersema D, Kornips B, Schyns-Soeterboek A, Visser LH, Schiphof P, Valkenburg A, Hiel J; FOCUS Extension Study Group. Jongen PJ, et al. Among authors: visser lh. J Neurol. 2014 Aug;261(8):1469-76. doi: 10.1007/s00415-014-7363-2. Epub 2014 May 3. J Neurol. 2014. PMID: 24792727 Free PMC article. Clinical Trial.
The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis.
van der Hiele K, van Gorp DA, Heerings MA, van Lieshout I, Jongen PJ, Reneman MF, van der Klink JJ, Vosman F, Middelkoop HA, Visser LH; MS@Work Study Group. van der Hiele K, et al. Among authors: visser lh. BMC Neurol. 2015 Aug 12;15:134. doi: 10.1186/s12883-015-0375-4. BMC Neurol. 2015. PMID: 26264389 Free PMC article.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: concept, content, and pilot results.
Jongen PJ, Sinnige LG, van Geel BM, Verheul F, Verhagen WI, van der Kruijk RA, Haverkamp R, Schrijver HM, Baart JC, Visser LH, Arnoldus EP, Gilhuis HJ, Pop P, Booy M, Lemmens W, Donders R, Kool A, van Noort E. Jongen PJ, et al. Among authors: visser lh. Patient Prefer Adherence. 2015 Dec 11;9:1741-50. doi: 10.2147/PPA.S93783. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26715841 Free PMC article.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Jongen PJ, Sinnige LG, van Geel BM, Verheul F, Verhagen WI, van der Kruijk RA, Haverkamp R, Schrijver HM, Baart JC, Visser LH, Arnoldus EP, Gilhuis HJ, Pop P, Booy M, Heerings M, Kool A, van Noort E. Jongen PJ, et al. Among authors: visser lh. Patient Prefer Adherence. 2016 Mar 3;10:243-50. doi: 10.2147/PPA.S93786. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27042018 Free PMC article.
An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
Jongen PJ, Heerings M, Ruimschotel R, Hussaarts A, Evers S, Duyverman L, Valkenburg-Vissers J, Cornelissen J, Bos M, van Droffelaar M, Lemmens WA, Donders R, van der Zande A, Visser LH. Jongen PJ, et al. Among authors: visser lh. BMC Neurol. 2016 May 28;16:81. doi: 10.1186/s12883-016-0593-4. BMC Neurol. 2016. PMID: 27234001 Free PMC article. Clinical Trial.
180 results